886762-70-5

Basic information

• Product Name: 1-Bromo-3-fluoro-2-nitrobenzene
• Synonyms: 1-Bromo-3-fluoro-2-nitrobenzene;2-fluoro-6-bromonitrobenzene;2-Bromo-6-fluoronitrobenzene 97%
• CAS NO: 886762-70-5
• Molecular Formula: C₆H₃BrFNO₂
• Molecular Weight: 220
• EINECS: 1533716-785-6
• Mol File: 886762-70-5.mol

Chemical Properties

• Melting Point: 36-37°C
• Boiling Point: 232 °C at 760 mmHg
• Flash Point: 94.1 °C
• Appearance: /
• Density: 1.808 g/cm³
• Vapor Pressure: 0.092mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: 2-8°C
• Solubility: soluble in Methanol
• CAS DataBase Reference: 1-Bromo-3-fluoro-2-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-3-fluoro-2-nitrobenzene(886762-70-5)
• EPA Substance Registry System: 1-Bromo-3-fluoro-2-nitrobenzene(886762-70-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/38
• Safety Statements: 36
• HazardClass: IRRITANT
• Hazardous Substances Data: 886762-70-5(Hazardous Substances Data)

Usage

Chemical Properties

light yellow crystalline powder

InChI:InChI=1/C6H3BrFNO2/c7-4-2-1-3-5(8)6(4)9(10)11/h1-3H

Upstream product

• 65896-11-9 2-bromo-6-fluoroaniline 
• 7632-04-4 sodium perborate 

Downstream Products

• 1092500-66-7 ethyl (3-bromo-2-nitrophenyl)glycinate 
• 1150617-53-0 3-bromo-N-methyl-2-nitrobenzenamine 
• 1239719-64-2 C₉H₁₁BrN₂O₂ 
• 1335114-90-3 C₁₅H₁₉FN₂O₆ 
• 1000339-52-5 3-fluoro-2-nitrobenzonitrile 
• 1240608-00-7 [3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-[2-(3-methoxyphenyl)-1-methyl-1H-benzoimidazol-4-yl]amine 
• 1240783-15-6 (2-isobutyl-1-methyl-1H-benzoimidazol-4-yl)-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]amine 
• 1240608-99-4 [2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]amine 
• 1240608-96-1 [2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]-[4-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]amine 
• 1240608-97-2 [2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]-[5-methoxy-6-(4-methylimidazol-1-yl)pyridin-3-yl]amine 
• 1240608-83-6 [2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]-[5-(4-methylimidazol-1-yl)pyridin-2-yl]amine 
• 1240608-28-9 [2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]-[6-(4-methylimidazol-1-yl)pyridin-3-yl]amine 
• 1240608-27-8 [3-fluoro-4-(4-methylimidazol-1-yl)phenyl]-[2-(4-fluorophenyl)-1-methyl-1H-benzoimidazol-4-yl]amine 
• 1381869-30-2 4-bromo-2-(3-methoxyphenyl)-1-methyl-1H-benzoimidazole 

Relevant articles and documents

Design of two new chemotypes for inhibiting the Janus kinase 2 by scaffold morphing

JAK2 is a target of high interest in chronic myeloproliferative disorders drug research. Starting from a screening hit, two new JAK2 inhibitor chemotypes were designed by scaffold morphing. The prototype compounds of these new series showed nanomolar inhi

Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors

We have designed and synthesized a novel series of 2,8-diaryl-quinoxalines as Janus kinase 2 inhibitors. Many of the inhibitors show low nanomolar activity against JAK2 and potently suppress proliferation of SET-2 cells in vitro. In addition, compounds from this series have favorable rat pharmacokinetic properties suitable for in vivo efficacy evaluation.

Synthesis of pyrrolnitrin and related halogenated phenylpyrroles

A general approach to halogenated arylpyrroles, including the antifungal natural product pyrrolnitrin, is described using newly synthesized halogenated pyrroles and 2,6-disubstituted nitrobenzenes or 2,6-disubstituted anilines.

Benzimidazolone and dihydroindolone derivatives and uses thereof

Compounds of the formula I: or pharmaceutically acceptable salts thereof wherein m, n, X, Ar, R1, R2, R3, R4 and R5 are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.